Literature DB >> 18266186

High incidence of tachyarrhythmias detected by an implantable loop recorder in patients with unexplained syncope.

Christina Schernthaner1, Franz Danmayr, Johann Altenberger, Maximilian Pichler, Bernhard Strohmer.   

Abstract

BACKGROUND: Syncope is a complex clinical syndrome that may be challenging with respect to a definite diagnosis. The implantable loop recorder (ILR) is a useful tool to define but also to exclude an arrhythmic aetiology. AIM: To investigate the causes of recurrent syncope or near-syncope with respect to underlying arrhythmias in non-selected consecutive patients monitored with an ILR.
METHODS: A retrospective study was conducted including 55 patients (34 men, 21 women; age 60+/-19 years) with unexplained syncope who received an ILR for prolonged monitoring at our institution between April 1998 and October 2006.
RESULTS: Forty (73%) patients had a recurrence of syncope or near-syncope. Structural heart disease was present in 18 (33%) patients, 4 of them having an ejection fraction <35%. An arrhythmia was detected as the cause of syncope in 25 (46%) patients. The ILR was successful in establishing a symptom-rhythm correlation in 63%. The mean follow-up period from implantation to occurrence of the detected arrhythmias was 9+/-8 months. Bradyarrhythmias were recorded in 12 (22%) patients, whereas tachyarrhythmias were found in 13 (24%) patients. Narrow QRS tachycardia was the underlying arrhythmia in 6 patients and wide QRS tachycardia in 7 patients. A pacemaker was implanted in all 12 patients with bradyarrhythmias. Implantable cardioverter defibrillator (ICD) therapy was indicated in 6 patients with adjunctive catheter ablation in 3 of them. Four patients presenting with paroxysmal supraventricular tachycardia were treated with radiofrequency catheter ablation.
CONCLUSION: The ILR helped efficaciously to determine the correct diagnosis and appropriate treatment of recurrent syncope. A considerably high proportion of tachyarrhythmias was detected in this non-selected consecutive population. The majority of patients with tachyarrhythmic syncope required defibrillator implantation and/or radiofrequency ablation.

Entities:  

Mesh:

Year:  2008        PMID: 18266186

Source DB:  PubMed          Journal:  Kardiol Pol        ISSN: 0022-9032            Impact factor:   3.108


  4 in total

1.  Holding Area LINQ Trial (HALT).

Authors:  John J Lee; Daniel Weitz; Rishi Anand
Journal:  Indian Pacing Electrophysiol J       Date:  2017-06-23

2.  Value of implantable loop recorders in patients with structural or electrical heart disease.

Authors:  Rafi Sakhi; Dominic A M J Theuns; Rohit E Bhagwandien; Michelle Michels; Arend F L Schinkel; Tamas Szili-Torok; F Zijlstra; Jolien W Roos-Hesselink; Sing-Chien Yap
Journal:  J Interv Card Electrophysiol       Date:  2018-03-13       Impact factor: 1.900

3.  Clinical predictors for bradycardia and supraventricular tachycardia necessitating therapy in patients with unexplained syncope monitored by insertable cardiac monitor.

Authors:  Tatsuya Onuki; Makoto Shoji; Hiroto Sugiyama; Shuhei Arai; Kosuke Yoshikawa; Hiroshi Mase; Masaaki Kurata; Miwa Kikuchi; Daisuke Wakatsuki; Taku Asano; Hiroshi Suzuki; Kaoru Tanno; Youichi Kobayashi; Toshiro Shinke
Journal:  Clin Cardiol       Date:  2021-03-16       Impact factor: 2.882

4.  Implant evaluation of an insertable cardiac monitor outside the electrophysiology lab setting.

Authors:  Roman Pachulski; James Cockrell; Hemant Solomon; Fang Yang; John Rogers
Journal:  PLoS One       Date:  2013-08-15       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.